Clinical trial
Chlorhydrate of Ropivacaine and Breast Cancer Surgery
NCT00370240 · Institut Curie, Other · Completed
Key facts
| NCT number | NCT00370240 |
|---|---|
| Title | Chlorhydrate of Ropivacaine and Breast Cancer Surgery |
| Official title | Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer. |
| Lead sponsor | Institut Curie, Other |
| Collaborators | AstraZeneca Industry Gustave Roussy, Cancer Campus, Grand Paris |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Pain, Postoperative |
| Intervention type | Drug, Other |
| Interventions | Chlorhydrate de Ropivacaine, placebo |
| Enrollment | 260 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Aug 31, 2006 |
| Last update posted | Sep 22, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: